_MACHINE TRANSLATION_
The Management Board of Bioceltix S.A., with its registered office in Wrocław (the “Issuer”, the “Company”), with reference to Current Report No. 12/2026 of 26 May 2026 concerning the convening of the Ordinary General Meeting for 23 June 2026, and Current Report No. 13/2026 of 2 June 2026 concerning amendments to the agenda of the Ordinary General Meeting at the request of a shareholder of the Company together with draft resolutions, hereby informs that today it received from a shareholder of the Issuer, TOTAL Closed‑End Investment Fund, represented and managed by IPOPEMA Towarzystwo Funduszy Inwestycyjnych S.A., a nomination of Mr. Szymon Ruta as a candidate for Member of the Supervisory Board of Bioceltix S.A., together with the candidate’s curriculum vitae and a statement confirming his consent to be appointed.
The professional résumé of the candidate received from the shareholder, together with the nomination, constitutes an attachment to this current report.
Attachments:
1. Professional résumé of the candidate.
20260619_ESPI_Raport_15_Zgłoszenie_Kandydata_RN_Załącznik_1
2. Nomination of the candidate.
20260619_ESPI_Raport_15_Zgłoszenie_Kandydata_RN_Załącznik_2
Signatures of persons authorised to represent the Company:
Łukasz Bzdzion – President of the Management Board
Paweł Wielgus – Member of the Management Board